Raymond James Financial Services Advisors’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $3.79M | Buy |
|
|||||
|
2024
Q2 | $3.45M | Buy |
|
|||||
|
2024
Q1 | $3M | Buy |
|
|||||
|
2023
Q4 | $2.9M | Buy |
|
|||||
|
2023
Q3 | $2.34M | Buy |
|
|||||
|
2023
Q2 | $1.84M | Buy |
|
|||||
|
2023
Q1 | $1.65M | Buy |
|
|||||
|
2022
Q4 | $1.28M | Buy |
|
|||||
|
2022
Q3 | $1.1M | Sell |
|
|||||
|
2022
Q2 | $1.11M | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $283K | Sell |
|
|||||
|
2021
Q3 | $368K | Buy |
|